Integral Health Asset Management’s Dyne Therapeutics DYN Stock Holding History

Integral Health Asset Management’s Portfolio DYN Stock Details DYN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-800,000	Closed	-$10.1M	–	89
2025 Q3	$10.1M	Buy	+800,000	New	+$9.12M	0.68%	52
2025 Q2	–	Sell	-450,000	Closed	-$4.71M	–	84
2025 Q1	$4.71M	Buy	450,000 +300,000	+200%	+$4.29M	0.5%	54
2024 Q4	$3.53M	Buy	+150,000	New	+$4.44M	0.3%	69
2024 Q3	–	Sell	-100,000	Closed	-$3.53M	–	73
2024 Q2	$3.53M	Buy	+100,000	New	+$2.91M	0.34%	62
2023 Q3	–	Sell	-62,000	Closed	-$698K	–	75
2023 Q2	$698K	Buy	62,000 +5,000	+9%	+$59K	0.09%	73
2023 Q1	$657K	Buy	+57,000	New	+$740K	0.13%	71

Other funds holding DYN

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Integral Health Asset Management's DYN Position: Q4 2025 in Review

Integral Health Asset Management sold out of Dyne Therapeutics (DYN) in Q4 2025, closing a stake of 800,000 shares — an estimated $10.1M sold.

Integral Health Asset Management first reported a position in DYN in Q1 2023 and held it in 6 quarters. The position peaked at $10.1M in Q3 2025. 232 funds tracked by Wall St. Rank hold DYN as of Q4 2025.

Integral Health Asset Management reported no remaining Dyne Therapeutics position as of Q4 2025 after selling out during the quarter.
Integral Health Asset Management sold 800,000 Dyne Therapeutics shares in Q4 2025, an estimated $10.1M.
Integral Health Asset Management first reported a position in Dyne Therapeutics in Q1 2023 and held it in 6 quarters.
Integral Health Asset Management's Dyne Therapeutics position peaked at $10.1M in Q3 2025.
232 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q4 2025.

Based on Integral Health Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.